SCHEMBL6407412

SCHEMBL6407412

Cn1c(=O)n(N)c(=O)c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.62
FEN1 P39748 1/20 0.62
ERCC4 Q92889 1/20 0.62
PGR P06401 1/20 0.59
NPEPPS P55786 1/20 0.51
GPR3 P46089 1/20 0.50
HSD17B10 Q99714 4/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 2/20 0.47
PKM P14618 1/20 0.47
CASP1 P29466 1/20 0.47
GALK1 P51570 1/20 0.47
BLM P54132 1/20 0.47
CASP7 P55210 1/20 0.47
SAE1 Q9UBE0 1/20 0.47
UBA2 Q9UBT2 1/20 0.47
KDM4E B2RXH2 4/20 0.46
NQO2 P16083 1/20 0.46
SLC9A1 P19634 1/20 0.46
ALDH1A1 P00352 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6366340 0.82 ERCC1 (0.69) ERCC1FEN1ERCC4PGRNPEPPS
SCHEMBL30665027 0.82 ERCC1 (0.69) ERCC1FEN1ERCC4PGRNPEPPS
SCHEMBL5143886 0.79 CYP1A2 (0.47) ERCC1FEN1ERCC4PGRGPR3
SCHEMBL6400912 0.78 PGR (0.64) PGRHSD17B10KMT2AGAACASP1
SCHEMBL17242776 0.77 ERCC1 (0.62) ERCC1FEN1ERCC4PGRNPEPPS
SCHEMBL19577294 0.77 PGR (0.64) ERCC1FEN1ERCC4PGRNPEPPS
SCHEMBL11394064 0.76 ERCC1 (0.61) ERCC1FEN1ERCC4PGRNPEPPS
SCHEMBL16352662 0.76 ERCC1 (0.61) ERCC1FEN1ERCC4PGRNPEPPS
SCHEMBL14692425 0.75 ERCC1 (0.56) ERCC1FEN1ERCC4PGRNPEPPS
SCHEMBL6360759 0.74 PGR (1.00) ERCC1FEN1ERCC4PGRNPEPPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 ERCC1 4830/4885FEN1 4681/4885ERCC4 4852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.